A Smart + Strong Site
Subscribe to:
POZ magazine

Back to home » Treatment News » Top Stories

July 30, 2014
Selzentry (Maraviroc) Fails to Best Truvada as First-Line Therapy
Selzentry failed in a head-to-head with Truvada as a first-line treatment for HIV when each were paired with Prezista.
Condom With Anti-HIV/STI Lube OK’d in Japan & Australia
A condom treated with an antiviral lubricant shown to fight HIV and other viral sexually transmitted infections has been approved in Japan and Australia.
July 29, 2014
European Health Agency Wants More Answers About PrEP
The European Centre for Disease Prevention and Control (ECDC) has stated that the agency is not ready to issue a recommendation about PrEP.
Male Circumcision Doesn’t Raise Sexual Risk-Taking in Zambia
Zamibian men who get circumcised as a part of a public health effort to reduce HIV risk do not seem to engage in riskier sexual behaviors as a result.
July 28, 2014
AbbVie’s '3D' Regimen Shows Promise in Those With Hep C & HIV
AbbVie’s “3D” regimen has shown high cure rates in treating genotype 1 of hepatitis C among those coinfected with HIV, both with and without cirrhosis.
Study on Intermittent Dosing of PrEP Suggests High Adherence
Early results of a study of an intermittent dosing strategy for PrEP have suggested that a high proportion of the participants are adhering well.
July 25, 2014
Drug Spurs Latently Infected Cells But Doesn’t Taper HIV Reservoir
Romidepsin, a cancer drug from the HDAC inhibitor class, awakened HIV-infected immune cells from latency, but it did not shrink the viral reservoir.
July 24, 2014
Scientists Devise Method of Snipping HIV From Immune Cells
Researchers have created a genetic treatment that, for the first time, has succeeded in removing HIV from infected human cells.
July 23, 2014
Expert Panel’s Advice for HIV Prevention Includes PrEP
A panel of HIV experts assembled by the International Antiviral Society has issued HIV prevention and treatment guidelines for clinicians that recommend an array of evidence-based biomedical and behavioral interventions and treatments.
Young Drug Users at Especially High Risk of HIV and Hep C
Over half of young injection drug users in the United States share syringes and about four in five report having sex without a condom.
European Economic Downturn Tied to HIV Uptick in Drug Users
The recent recession in Europe and expanding income inequality have been linked to increased rates of HIV in injection drug users in the region.
Gilead Reaps $3.48 Billion in Second Quarter Sovaldi Sales
With $3.48 billion in sales of the hepatitis C drug Sovaldi, Gilead Sciences reported a second-quarter revenue of $6.53 billion.
July 22, 2014
Treating Early May Limit HIV Reservoir, But Virus Still Rebounds
Very early treatment limits the size of the viral reservoir in primates infected with an HIV-like virus, but the virus still rebounds after treatment interruption.
100% Efficacy for Gays Who Adhered in PrEP Study; Most Didn’t
Gay men and trans women mostly adhered poorly to Truvada as PrEP in a recent study, but were totally protected against HIV if they took the drug four or more days a week.
Circumcision Reduces Syphilis Rates in Both Men and Women
male circumcision reduced syphilis incidence by 42 percent in men and by 59 percent in their female partners
Sovaldi and Ribavirin Cure High Rates of Those With HIV & Hep C
Sovaldi (sofosbuvir) and ribavirin cured between 84 percent and 91 percent of people coinfected with HIV and genotypes 1 through 4 of hepatitis C.
It's Time to 'Step Up the Pace' Against Global HIV
Accelerating the response to the global HIV epidemic requires targeting key affected populations and tailoring efforts around geographic particulars, and it should involve amped up testing and treatment for the virus.
July 21, 2014
PrEP May Be Safe for Women Seeking to Get Pregnant
Truvada as pre-exposure prophylaxis may be safe for the pregnancies of HIV-negative women when taken until just after conception.
Only 1 in 5 Sexually Active High Schoolers Have Had an HIV Test
Just 22 percent of U.S. high school students who reported intercourse last year have ever received an HIV antibody test.
Egrifta Can Reduce Abdominal and Liver Fat in People With HIV
The injectable drug Egrifta (tesamorelin) led to modest drops in abdominal and liver fat levels in a preliminary study of people with HIV.
As Global Pandemic Abates, 54% of Those With HIV Are Unaware
A new UNAIDS report celebrates significant drops in global HIV incidence and AIDS-related deaths while outlining ways to address inequities of the pandemic.
July 18, 2014
Gay Men Who Discuss HIV Before Sex More Likely to Stay Negative
A new study of German gay men finds that those who discuss HIV before sex are much less likely to acquire the virus.
July 17, 2014
People With Both HIV & Hep C Have Raised Risk of Bone Loss
People coinfected with HIV and hepatitis C have a higher risk of osteoporosis and bone fracture than those who are infected with just HIV.
July 16, 2014
Sustiva (Efavirenz) Linked to Doubled Risk of Suicidality
People with HIV starting treatment regimens containing Sustiva have a more than doubled risk of suicidal thoughts, attempts and completed attempts.
July 15, 2014
Many People With HIV Could Switch to Newer, Safer Regimens
A majority of people taking antiretrovirals to treat HIV could switch to newer regimens with improved side effect profiles.
July 12, 2014
WHO Supports PrEP, Media Bungles The Story With Hyperbole
The World Health Organization has for the first time thrown its support behind the use of pre-exposure prophylaxis (PrEP to prevent HIV among gay men. 
July 11, 2014
HIV Returns in the 'Mississippi Baby' Once Thought Cured
The child has experienced a resurgence of the virus and is once again taking antiretroviral therapy.
July 10, 2014
PrEP May Reduce Risk of Herpes By a Third
Pre-exposure prophylaxis (PrEP) to prevent getting HIV may also lower the risk of contracting herpes.
July 09, 2014
WHO TasP Guidelines Will Benefit Few in the Ivory Coast
The WHO 2013 guidelines for using antiretrovirals to prevent the transmission of HIV will benefit a fraction of the targeted group in the Ivory Coast.
July 08, 2014
Intervention Boosts Minority Participation in HIV Studies
Researchers have devised an intervention that vastly increases African-American and Latino participation in HIV/AIDS medical studies.
July 07, 2014
People With HIV Less Likely to Receive Cancer Treatment
HIV-positive people are less likely to receive treatment for cancer than those who are not living with the virus.
July 03, 2014
Starting ARVs Soon After Birth Can Vastly Reduce HIV Reservoir
Treating HIV-positive infants with an aggressive regimen of HIV meds shortly after birth can greatly reduce the establishment of the viral reservoir.
July 02, 2014
Herpes Drives Heterosexual Transmission of HIV in NYC
Infection with herpes simplex virus 2 is propelling significant increases in the prevalence of HIV among non-injecting drug users in New York City.
July 01, 2014
Gay Men at Risk May Not See Themselves as PrEP Candidates
A significant proportion of gay and bi men attending New York City sex venues mistakenly qualified themselves as not being candidates for PrEP.
Most Popular Stories
An Almost Normal Life Expectancy for People With HIV?
Undetectable Viral Load Essentially Eliminates Transmission Risk in Straight Couples
A 15-Year Jump in Life Expectancy for People With HIV
Misleading News Reports Suggest HIV Cure Is Near
New HIV Drug Class Shows Promise
Gene Therapy Shows Promise in Controlling HIV
Potential Microbicide Tricks HIV Into Sudden Death
Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?

July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
February 2006
October 2005

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Conference Coverage
Health Services Directory
POZ Magazine

    New York
    New York

    New York
    New York

    Palm Springs

Click here to join POZ Personals!
Conference Coverage

21st Conference on Retroviruses and Opportunistic Infections
(CROI 2014)
Boston, MA
March 3 - 7, 2014

7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
(IAS 2013)
Kuala Lumpur, Malaysia
June 30 - July 3, 2013

20th Conference on Retroviruses and Opportunistic Infections
(CROI 2013)
Atlanta, GA
March 3 - 7, 2013

more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.